Global Siponimod Market Size, Share and Trends Analysis Report, By Type (0.25mg, 0.2mg), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy), Forecast (2022-2028)

The global siponimod market is anticipated to grow at a significant CAGR 6% during the forecast period (2022-2028). According to Health Canada siponimod is a modulator for the sphingosine 1-phosphate (S1P) receptor available as oral film-containing tablets containing 0.25 mg or 2 mg siponimod. The health Canada indication is for the treatment of patients with SPMS with active disease evidenced by relapses or inflammatory function of MS, delaying the progression of physical disability.  The growing prevalence of SPMS is anticipated to drive the global market. The titration regimen covers a period of six days to a maximum of 2 mg in the 6th day.

At the time of the study, more than 80.0% of respondents living with SPMS were not taking DMT, while about 30.0% were taking some form of treatment. When asked about their drug perspective after being given a list of common side effects associated with siponimod, 36.0% of respondents said they would take siponimod, 35.0% said they would not take siponimod due to a lack of the long-term data market, and 28.0% said they did not know. The MS Society of Canada expects that siponimod treatment may have the potential to allow people living with SPMS to stay active, advance family and social roles and responsibilities longer, improve their quality of life, reduce the need for care, and reduce stress the financial burden on health and social systems.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-Novartis, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Siponimod Market Report by Segment

By Type

• 25mg
• 2mg

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy

Global SiponimodMarket Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa